CARM Carisma Therapeutics
- 0.885
- -0.016-1.74%
- 0.914
- +0.029+3.28%
Carisma Therapeutics News
Carisma Therapeutics | 10-Q: Quarterly report
Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thorell Marella
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Scadden David
Carisma Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Thorell Marella
Carisma Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Scadden David
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ZWEIFACH SANFORD S
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hohneker John
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Torok Michael
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Morris Richard Steven
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klichinsky Michael
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Steven
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-HealthCap VII, L.P.(8.2%),HealthCap VII GP LLC(8.2%)
Analysis
Price Target
No Data
